Promega helps researchers plumb the depths of the life sciences. The company sells more than 2,000 products that allow scientists to conduct various experiments in gene, protein, and cellular research. Its offerings fall into more than two dozen categories, including DNA and RNA purification, genotype analysis, protein expression and analysis, and DNA sequencing. Promega has branches in 15 countries around the world. The firm sells its products directly and through about 50 distributors. Customers include academic, pharmaceutical, and clinical labs, as well as government agencies and energy and chemical companies.
Promega has branches in 15 countries with more than 50 global distributors serving 100 countries. The company's headquarters are located in Madison, Wisconsin. Promega Biosciences (PBI) is located in San Luis Obispo, California while Promega BioSystems (PBS) is located in Sunnyvale, California. The company recently opened new facility for its China operations, replacing an existing molecular biology reagent production site.
Promega Biosciences (PBI) combines research in chemistry and manufacturing to serve the scientific community. Promega BioSystems (PBS) designs and manufactures single-tube and microplate readers for fluorescent and luminescent biological assays.
Subsidiary Terso Solutions provides inventory management services to distributors, hospitals, laboratories, and manufacturers. The company's system uses radio-frequency identification (RFID) enabled cabinets, freezers, and refrigerators to help clients keep tabs on the whereabouts of sensitive inventory such as reagents, pharmaceuticals, and hazardous materials. RFID uses radio-wave communication technology to exchange data between a reader and an electronic tag attached to the item being tracked. The technology allows users to maintain close tabs on the supply management chain, usually via web-based applications, in effort to control costs.
Sales and Marketing
Promega's clients use its products predominantly for life science research in the fields of genomics, proteomics (the study of proteins), and cellular analysis with the ultimate goal of indentifying targets for drug development. Additionally, its products are used for forensic testing by state and federal agencies, including the Federal Bureau of Investigation, for human identification. Promega also offers paternity testing kits and in vitro diagnostic test systems.
Promega is continuously growing its product offerings through research and development efforts; R&D spending accounts for more than 10% of annual revenue expenditures. It focuses on expanding the uses of its current technologies, as well as introducing new add-ons for existing systems and kits. The company also licenses its technologies to other biotech firms.
Promega sometimes partners with other companies to expand its service offerings. In late 2010 Promega and MS Bioworks formed a collaboration through which the two companies began offering mass spectrometry services including sample processing and analysis.
Following that, Promega formed a partnership with American Type Culture Collection (ATCC) for cell banking and bioproduction of cells to create a new line of bioluminescence-based drug discovery assays for biologics. Under terms of the deal, ATCC will produce and authenticate the cell banks and stock cell lines, which will be used as cellular reagents to create a new line of Promega cell assay systems for biologics. The initial cell assay system will facilitate biologics drug discovery. Additionally, Promega will launch an ADCC reporter bioassay in 2011 as the first product offering from the partnership.
Promega was founded in 1978 and is owned by investors and employees and led by founder and CEO William Linton.